All In Biotech

Drug Trial Radar · NCT02802228

Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients

A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients

Last checked: Nov 19, 2026Latest source record: Jan 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Mar 6, 2017

Primary completion

Jul 17, 2018

Study completion Jul 17, 2018

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jun 16, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This placebo-controlled study will assess the safety and efficacy of a 90-day course of treatment with ifetroban for portal hypertension in cirrhotic patients

Conditions

  • Portal Hypertension
  • Liver Cirrhosis

Interventions

  • IfetrobanDrug

    thromboxane prostanoid receptor antagonist delivered as infusion and oral capsule

  • PlaceboDrug

    matched placebo delivered as infusion and oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety (Incidence and Severity of Adverse Events)Time frame: Through 97 days (90 days treatment and 7 days follow-up)
  2. Safety (Severity of Adverse Events)Time frame: Through 90 days treatment and 7 days follow-up

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Tampa General Medical Group

    Tampa, Florida

  • Indiana University

    Indianapolis, Indiana

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Medical University of South Carolina

    Charleston, South Carolina

  • Baylor University Medical Center

    Dallas, Texas

  • Virginia Commonwealth University Medical Center

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.